| Literature DB >> 35160134 |
Gustavo Rodríguez-Fuentes1, Lucía Silveira-Pereira2, Pedro Ferradáns-Rodríguez2, Pablo Campo-Prieto1.
Abstract
The Pilates Method is a rehabilitation tool with verified benefits in pain management, physical function, and quality of life in many different physiotherapy areas. It could be beneficial for patients with multiple sclerosis (pwMS). The aim of the study was to summarize current evidence for the effectiveness of Pilates in pwMS. A comprehensive search of Cinahl, Scopus, Web of Science, PEDro, and PubMed (including PubMed Central and Medline) was conducted to examine randomized controlled trials (RCT) that included Pilates intervention in multiple sclerosis. The PEDro scale and the Cochrane risk-of-bias tool, RoB-2, were used to evaluate risk of bias for RCT. Twenty RCT (999 patients) were included. Ten were of good quality (PEDro), and seven had low risk of bias (RoB-2). Pilates improves balance, gait, physical-functional conditions (muscular strength, core stability, aerobic capacity, and body composition), and cognitive functions. Fatigue, quality of life, and psychological function did not show clear improvement. There was good adherence to Pilates intervention (average adherence ≥ 80%). Cumulative data suggest that Pilates can be a rehabilitation tool for pwMS. High adherence and few adverse effects were reported. Future research is needed to develop clinical protocols that could maximize therapeutic effects of Pilates for pwMS.Entities:
Keywords: exercise therapy; multiple sclerosis; neurorehabilitation; physical therapy modalities; pilates-based exercise
Year: 2022 PMID: 35160134 PMCID: PMC8836864 DOI: 10.3390/jcm11030683
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1PRISMA flow chart of the study selection.
Main findings of the reviewed studies.
| Variables | Main Findings with Pilates Method | Other Findings |
|---|---|---|
| Balance |
Significant improvement [ Significant improvement compared with physician care [ |
No significant differences between Pilates and rebound therapy [ |
| Gait |
Significant improvement [ Significant improvement compared with standard physiotherapy care [ |
No significant improvement [ Significant improvement in standardized exercises group compared to Pilates group [ |
| Physical-functional conditions |
Significant improvement in muscle strength [ Significant improvement in core stability [ Significant improvement in physical performance [ Significant improvement in aerobic capacity [ Significant improvement in body composition [ | |
| Fatigue |
Significant improvement [ |
No significant improvement in post-intervention Pilates group, but there was in aerobic exercise group [ |
| Quality of life |
Significant improvement [ Significant improvement compared with traditional exercises group [ |
No difference between Pilates + a 1-h massage therapy group and a 1-h massage therapy group [ |
| Cognitive function |
Significant improvement [ Significant improvement compared with home relaxation exercises group [ | |
| Psychological function |
Significant improvement in depression symptoms [ Significant improvement in anxiety [ Significant improvement in depression symptoms and anxiety compared with wait-list group [ |
Significant improvement in home-based Pilates group compared with supervised Pilates group in anxiety symptoms [ No significant improvement in depression symptoms [ |
| Adherence |
Average adherence to the treatment above 80–85% [ |
Lack of compliance values [ Higher compliance in standardized exercises group or relaxation group than Pilates group [ |
| Adverse effects and dropouts |
9 cases of adverse effects [ 62 dropouts in Pilates groups [ |
3 cases of adverse effects in no-Pilates groups [ 45 dropouts in no-Pilates groups [ 24 dropouts in unspecified group [ Don’t know the dropouts [ Don’t know the adverse effects cases [ |
Pilates intervention characteristics of reviewed studies.
| Study and Year | MS Type (Patients in Pilates Group) | Mean EDSS Score ± sd (Range) | Weeks | Session per Week | Session Duration (min) | Type of Pilates | Pilates Session (Number When Conducted in Group) | Professional | Adverse Events (Case) | Pilates Training Program |
|---|---|---|---|---|---|---|---|---|---|---|
| Güngör et al. [ | RRMS (34)/SPMS (8) | (1–5.5) | 8 | 2 | 60–75 | Floor mat work | Individual | Physiotherapist | No | Yes (in |
| Fleming et al. [ | NA | <3 (PDDS) | 8 | 2 | 60 | Floor mat work | Individual | Certified Pilates instructor | No | Yes (in a previous study) |
| Gheitasi et al. [ | NA | 4.6 ± 1.6 (3–5) | 12 | 3 | 60 | Floor mat work | Unclear | NA | No | No |
| Arntzen et al. [ | RRMS (32)/PPMS (5)/SPMS (2) | 2.45 ± 1.65 (1–6.5) | 6 | 3 | 60 | Floor mat work | Group (3) | Neurological physiotherapists | Yes (1) | Yes (in a previous study) |
| Ozkul et al. [ | RRMS (17) | 1.50 ± 0.77 (<4) | 8 | 3 | 60 | Floor mat work | NA | Physiotherapist | No | Yes |
| Banitalebi et al. [ | RRMS (47) | 23 (0–4) + 13 (4.5–6) + 11 (6.5–8) | 12 | 3 | 15/100 | NA | NA | NA | NA | No |
| Abasiyanik et al. [ | RRMS (14)/SPMS (2) | 3.06 ± 1.65 (<6) | 8 | 1 (+2 at home) | 55–60 | Floor mat work | Group (2–3) | Certified Pilates physiotherapist | No | Yes |
| Fleming et al. [ | NA | <3 (PDDS) | 8 | 2 | 60 | Floor mat work | Individual | Certified Pilates instructor | No | Yes |
| Eftekhari and Etemadifar [ | RRMS (13) | 2–6 | 8 | 3 | 50–60 | Floor mat work | NA | NA | NA | Yes |
| Ozkul tel al. [ | RRMS | 1 (0.87–2.12) | 8 | 3 | 60 | Floor mat work | NA | Physiotherapist | Yes (3) | Yes |
| Duff et al. [ | RRMS (14)/PPMS (1) | 2.1 ± 1.8 (range 0–5, PDDS) | 12 | 2 | 50 | Apparatus work and floor mat work | Group (5–10) | Certified Pilates instructor | No | No |
| Eftekhari and Etemadifar [ | RRMS(13) | 2–6 | 8 | 3 | 40–50 | Floor mat work | NA | NA | NA | Yes |
| Kalron et al. [ | RRMS (22) | 4.3 ± 1.3 (3–6) | 12 | 1 | 30 | NA | Individual | Certified Pilates physiotherapist | No | No |
| Bulguroglu et al. [ | NA | <4.5 | 8 | 2 | 60–90 | Floor mat work or Reformer work | Individual | Certified Pilates physiotherapist | NA | No |
| Kara et al. [ | RRMS (9) | 2.85 ± 1.57 (≤6) | 8 | 2 | 45–60 | Floor mat work | NA | Physiotherapist | Yes (4) | Yes |
| Fox et al. [ | RRMS (13/PPMS (12)/SPMS (8) | 4–6.5 | 12 | 1 | 30 | Floor mat work | Individual | Certified Pilates physiotherapist | No | Yes (in a previous study) |
| Küçük et al. [ | NA | 3.2 ± 2.2 (≤6) | 8 | 2 | 45–60 | Floor mat work | Group | Physiotherapist | NA | Yes |
| Hosseini Sisi et al. [ | NA | 0–4 | 8 | 3 | 60 | NA | NA | NA | NA | No |
| Guclu-Cunduz et al. [ | NA | 2 (0–4) | 8 | 2 | 60 | NA | Group | Certified Pilates physiotherapist | No | No |
| Marandi et al. [ | NA | <4.5 | 12 | 3 | 60 | NA | NA | NA | NA | No |
EDSS: Expanded Disability Status Scale; min: minute; MS: multiple sclerosis; NA: not available; PDDS: Patient-Determined Disease Steps; PPMS: primary progressive multiple sclerosis; RRMS: relapsing-remitting multiple sclerosis; sd: standard deviation; SPMS: secondary progressive multiple sclerosis.
Methodological quality assessment of the reviewed studies using PEDro scale, and sample size calculation.
| Study and Year | Sample Size Calculation | #1 | #2 | #3 | #4 | #5 | #6 | #7 | #8 | #9 | #10 | #11 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Güngör et al. [ | Yes | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 6/10 |
| Fleming et al. [ | Yes | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 7/10 |
| Gheitasi et al. [ | Yes | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 7/10 |
| Arntzen et al. [ | Yes | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 8/10 |
| Ozkul et al. [ | Yes | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 8/10 |
| Banitalebi et al. [ | No | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 6/10 |
| Abasiyanik et al. [ | Yes | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 4/10 |
| Fleming et al. [ | No | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 4/10 |
| Eftekhari and Etemadifar [ | No | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 5/10 |
| Ozkul tel al. [ | Yes | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 6/10 |
| Duff et al. [ | Yes | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 7/10 |
| Eftekhari and Etemadifar [ | No | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 4/10 |
| Kalron et al. [ | No | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 7/10 |
| Bulguroglu et al. [ | No | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 5/10 |
| Kara et al. [ | No | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 3/10 |
| Fox et al. [ | Yes | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 8/10 |
| Küçük et al. [ | No | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 5/10 |
| Hosseini Sisi et al. [ | No | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 3/10 |
| Guclu-Cunduz et al. [ | No | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 5/10 |
| Marandi et al. [ | No | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 3/10 |
| 17 | 16 | 9 | 15 | 1 | 0 | 10 | 10 | 6 | 15 | 17 |
#1, eligibility criteria (not included in the total score); #2, random allocation; #3, concealed allocation; #4, baseline comparability; #5, participant blinding; #6, therapist blinding; #7, assessor blinding; #8, outcomes were obtained from more than 85%; #9, intention to treat analysis; #10, between-group difference; #11, point estimates and variability.
Figure 2Risk of bias of the reviewed studies: (up) for each domain, (down) overall judgement.